Announcement
19 Jul 2024
In July 2024, US BARDA awarded USD 25 million to Walgreens to design and conduct a decentralized Phase IV COVID-19 vaccine clinical trial focusing on retail pharmacy locations.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
19 Jul 2024
Revocation date:
No revocation date
Updated: 19 Jul 2024
State aid, unspecified
In force
On 19 July 2024, the Biomedical Advanced Research and Development Authority (BARDA) provided USD 25 million in funding to Walgreens USA to carry out a one-year follow-up clinical trial. The trial a...
Sign in to see more
Threads
See all
This state act is not part of any Thread yet.